The Lancet Diabetes and Endocrinology
Импакт-Фактор - Анализ · Тренд · Рейтинг · Прогноз
Импакт-Фактор
2019-2020
25.34
Тенденция Импакт-Фактор
The Lancet Diabetes and Endocrinology Импакт-Фактор
Импакт-Фактор The Lancet Diabetes and Endocrinology на 2019-2020 годы составляет 25.34, он обновлен только в 2020 году.
The Lancet Diabetes and Endocrinology - Journal Impact IF
The 2019-2020 Journal Impact IF of The Lancet Diabetes and Endocrinology is 25.34, which is just updated in 2020.
The highest Импакт-Фактор of The Lancet Diabetes and Endocrinology is 25.34.
The lowest Импакт-Фактор of The Lancet Diabetes and Endocrinology is 9.185.
The total growth rate of The Lancet Diabetes and Endocrinology IF is 175.9%.
The annual growth rate of The Lancet Diabetes and Endocrinology IF is 29.3%.
Рейтинг Импакт-Фактор
| Подкатегория | Квартиль | Классифицировать | Процент |
|---|---|---|---|
| Internal Medicine | Q1 | 1/128 |
Internal Medicine 99% |
| Endocrinology, Diabetes and Metabolism | Q1 | 1/217 |
Endocrinology, Diabetes and Metabolism 99% |
| Endocrinology | Q1 | 1/118 |
Endocrinology 99% |
· In the Internal Medicine research field, the Quartile of The Lancet Diabetes and Endocrinology is Q1. The Lancet Diabetes and Endocrinology has been ranked #1 over 128 related journals in the Internal Medicine research category. The ranking percentile of The Lancet Diabetes and Endocrinology is around 99% in the field of Internal Medicine.
The Lancet Diabetes and Endocrinology Key Factor Analysis
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of The Lancet Diabetes and Endocrinology is Q1. The Lancet Diabetes and Endocrinology has been ranked #1 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of The Lancet Diabetes and Endocrinology is around 99% in the field of Endocrinology, Diabetes and Metabolism.
The Lancet Diabetes and Endocrinology Key Factor Analysis
· In the Endocrinology research field, the Quartile of The Lancet Diabetes and Endocrinology is Q1. The Lancet Diabetes and Endocrinology has been ranked #1 over 118 related journals in the Endocrinology research category. The ranking percentile of The Lancet Diabetes and Endocrinology is around 99% in the field of Endocrinology.
The Lancet Diabetes and Endocrinology Key Factor Analysis
Связанные академические журналы
Тенденция международного сотрудничества
Цитированные документы Тенденция
История Импакт-Фактор
| Год | Импакт-Фактор |
|---|---|
| Год | Импакт-Фактор |
| 2019-2020 | 25.34 |
| 2018-2019 | 24.54 |
| 2017-2018 | 19.313 |
| 2016-2017 | 19.742 |
| 2015-2016 | 16.32 |
| 2014-2015 | 9.185 |
| 2013-2014 | - |
| 2012-2013 | - |
| 2011-2012 | - |
· The 2019-2020 Импакт-Фактор of The Lancet Diabetes and Endocrinology is 25.34
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2018-2019 Импакт-Фактор of The Lancet Diabetes and Endocrinology is 24.54
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2017-2018 Импакт-Фактор of The Lancet Diabetes and Endocrinology is 19.313
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2016-2017 Импакт-Фактор of The Lancet Diabetes and Endocrinology is 19.742
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2015-2016 Импакт-Фактор of The Lancet Diabetes and Endocrinology is 16.32
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2014-2015 Импакт-Фактор of The Lancet Diabetes and Endocrinology is 9.185
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Импакт-Фактор 2013-2014 of The Lancet Diabetes and Endocrinology is still under analysis. Stay Tuned!
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Импакт-Фактор 2012-2013 of The Lancet Diabetes and Endocrinology is still under analysis. Stay Tuned!
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Импакт-Фактор 2011-2012 of The Lancet Diabetes and Endocrinology is still under analysis. Stay Tuned!
The Lancet Diabetes and Endocrinology Key Factor Analysis
Вступление
Each monthly issue of The Lancet Diabetes & Endocrinology features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. The journal publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.
The ISSN of The Lancet Diabetes and Endocrinology is
2213-8587
.
An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The ISSN (Online) of The Lancet Diabetes and Endocrinology is
2213-8595
.
An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Lancet Diabetes and Endocrinology is published by
Elsevier BV
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Lancet Diabetes and Endocrinology publishes reports
-
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Publication History of The Lancet Diabetes and Endocrinology covers
2013 - Present
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Lancet Diabetes and Endocrinology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.
The Lancet Diabetes and Endocrinology Key Factor Analysis
There is no publication fee for submiting manuscript to The Lancet Diabetes and Endocrinology. The Lancet Diabetes and Endocrinology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The language of The Lancet Diabetes and Endocrinology is
-
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The publisher of The Lancet Diabetes and Endocrinology is
Elsevier BV
,
which locates in
Netherlands
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
Популярные академические журналы
Что такое импакт-фактор?
Импакт-фактор (IF) часто используется как индикатор важности журнала для своей области. Впервые он был представлен Юджином Гарфилдом, основателем Института научной информации. Хотя ИФ широко используется учреждениями и врачами, люди имеют широко распространенное заблуждение относительно метода расчета журнального ИФ, его значимости и того, как его можно использовать. IF журнала не связан с такими факторами, как качество процесса рецензирования и качество содержания журнала, но является мерой, которая отражает среднее количество цитирований статей, опубликованных в журналах, книгах, диссертациях, отчетах о проектах, газетах. , материалы конференций / семинаров, опубликованные в Интернете документы, заметки и любые другие утвержденные документы.
Импакт-фактор обычно используется для оценки относительной важности журнала в своей области и для измерения частоты цитирования «средней статьи» в журнале за определенный период времени. Журнал, который публикует больше обзорных статей, получит самые высокие IF. Журналы с более высокими значениями IF считаются более важными, чем журналы с более низкими значениями. По словам Юджина Гарфилда, «влияние просто отражает способность журналов и редакторов привлекать лучшую доступную бумагу». Журнал, который публикует больше обзорных статей, получит максимальное количество IF.
What is Impact Factor?
The impact factor (IF) is frequently used as an indicator of the importance of a journal to its field. It was first introduced by Eugene Garfield, the founder of the Institute for Scientific Information. Although IF is widely used by institutions and clinicians, people have widespread misconception regarding the method for calculating the journal IF, its significance and how it can be utilized. The IF of a journal is not associated to the factors like quality of peer review process and quality of content of the journal, but is a measure that reflects the average number of citations to articles published in journals, books, thesis, project reports, newspapers, conference/seminar proceedings, documents published in internet, notes, and any other approved documents.
Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs.